Condensed Statement of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Shareholders' deficiency, Beginning balance at Jan. 31, 2012	$ (90,807)	$ 1,233	$ 81,323	$ (173,363)	$ 0
Common stock, shares outstanding, Beginning balance at Jan. 31, 2012	1,233,853	1,233,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(69,767)			(39,675)	(30,092)
Shareholders' deficiency, Ending balance at Oct. 31, 2012	$ (160,574)	$ 1,233	$ 81,323	$ (213,038)	$ (30,092)
Common stock, shares outstanding, Ending balance at Oct. 31, 2012	1,233,853	1,233,853